BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9973565)

  • 1. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
    Morris MC; Divita G
    J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of cyclins with cyclin-dependent kinases: a common interactive mechanism.
    Heitz F; Morris MC; Fesquet D; Cavadore JC; Dorée M; Divita G
    Biochemistry; 1997 Apr; 36(16):4995-5003. PubMed ID: 9125522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of dimerization and interactions of p13suc1 with cyclin-dependent kinases.
    Morris MC; Heitz F; Divita G
    Biochemistry; 1998 Oct; 37(40):14257-66. PubMed ID: 9760264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclins and the G2/M transition.
    Jackman MR; Pines JN
    Cancer Surv; 1997; 29():47-73. PubMed ID: 9338096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal control of the dephosphorylation of Cdk substrates by mitotic exit pathways in budding yeast.
    Jin F; Liu H; Liang F; Rizkallah R; Hurt MM; Wang Y
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16177-82. PubMed ID: 18845678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative role for cell cycle-related proteins in microtubule-based neuroplasticity.
    Schmetsdorf S; Arnold E; Holzer M; Arendt T; Gärtner U
    Eur J Neurosci; 2009 Mar; 29(6):1096-107. PubMed ID: 19302146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple levels of cyclin specificity in cell-cycle control.
    Bloom J; Cross FR
    Nat Rev Mol Cell Biol; 2007 Feb; 8(2):149-60. PubMed ID: 17245415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
    Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
    J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.
    Upton JW; Speck SH
    J Virol; 2006 Dec; 80(24):11946-59. PubMed ID: 17005668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CDK/cyclin complexes in transcription and RNA splicing.
    Loyer P; Trembley JH; Katona R; Kidd VJ; Lahti JM
    Cell Signal; 2005 Sep; 17(9):1033-51. PubMed ID: 15935619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
    Dinarina A; Santamaria PG; Nebreda AR
    FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.
    Hu X; Cui D; Moscinski LC; Zhang X; Maccachero V; Zuckerman KS
    Cytokine; 2007 Feb; 37(2):155-62. PubMed ID: 17459720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
    Kõivomägi M
    Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of plant cyclin-dependent kinase activity using immunoprecipitation-coupled and affinity purification-based kinase assays and the baculovirus expression system.
    Harashima H; Sekine M
    Methods Mol Biol; 2011; 779():65-78. PubMed ID: 21837561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and biochemical analysis of catalytically active human cdc25C dual specificity phosphatase.
    Franckhauser C; Fernandez A; Lamb NJ
    Biochimie; 2013 Jul; 95(7):1450-61. PubMed ID: 23567337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.